A Circulating MicroRNA-375 for the Detection of Liver Cancer: A Meta-Analysis
- 1 December 2022
- journal article
- research article
- Published by Mary Ann Liebert Inc in Genetic Testing and Molecular Biomarkers
- Vol. 26 (12), 564-572
- https://doi.org/10.1089/gtmb.2022.0128
Abstract
Background: Liver cancer is one of the most frequently diagnosed malignant tumors, with an extremely high incidence rate. Diagnosis of liver cancer is difficult with the existing methods and improved biomarkers are urgently needed. A number of studies have established a link between abnormal miR-375 expression and liver cancer. Therefore, we conducted a systematic analysis to appraise whether miR-375 can be used as a screening tool for liver cancer detection. Methods: Through a systematic database search, studies investigating miR-375 expression in serum by the quantitative real-time reverse transcription-PCR (qRT-PCR) method were included in the study. A total of 1,100 participants (576 with liver cancer and 534 without liver cancer) were recruited. The efficacy of microRNA-375 in the detection of liver cancer was assessed by sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under curve (AUC). Results: The pooled sensitivity and specificity of miR-375 in the detection of liver cancer were 0.91 (95% confidence interval [CI]: 0.74–0.98) and 0.83 (95% CI: 0.67–0.92), respectively. Furthermore, the pooled PLR was 5.40 (95% CI: 2.58–11.31), NLR was 0.10 (95% CI: 0.03–0.36), DOR was 52.52 (95% CI: 10.02–275.42), and AUC was 0.93 (95% CI: 0.90–0.95), indicating that miR-375 is effective at detecting liver cancer. Conclusions: According to our meta-analysis, measuring serum miR-375 has high sensitivity and specificity, which will facilitate its clinical application in liver cancer monitoring.Keywords
This publication has 33 references indexed in Scilit:
- Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinomaTumor Biology, 2015
- Systematic Review and Meta‐Analysis: Circulating miRNAs for Diagnosis of Hepatocellular CarcinomaJournal of Cellular Physiology, 2015
- Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma ScreeningMedicine, 2015
- Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinomaTumor Biology, 2015
- A MDM2‐dependent positive‐feedback loop is involved in inhibition of miR‐375 and miR‐106b induced by Helicobacter pylori lipopolysaccharideInternational Journal of Cancer, 2014
- Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinomaDiagnostic Pathology, 2014
- Convincing Evidence from Controlled and Uncontrolled Studies on the Lipid-Lowering Effect of a StatinPublished by Wiley ,2012
- MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivoOncogene, 2011
- Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive HepatocarcinomaCancer Research, 2010
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006